0R15 8884.0068 1.4156% 0R1E 9171.0 0.4381% 0M69 None None% 0R2V 255.53 6.2495% 0QYR 1619.0 1.9521% 0QYP 439.6 -0.2043% 0RUK None None% 0RYA 1532.0 -4.0701% 0RIH 190.8 0.0% 0RIH 193.5 1.4151% 0R1O 226.72 9954.102% 0R1O None None% 0QFP None None% 0M2Z 255.4879 -0.0829% 0VSO 33.09 -7.0636% 0R1I None None% 0QZI 599.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 227.3 2.2952%

Plant Health Care

Basic Materials GB PHC

NoneGBP
-(-%)

Last update at 2024-09-19T08:00:40.640902Z

Day Range

--
LowHigh

52 Week Range

3.2012.15
LowHigh

Fundamentals

  • Previous Close 8.93
  • Market Cap12.81M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-5.38700M
  • Revenue TTM11.82M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 5.00M
  • Diluted EPS TTM-0.01

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -9.44700M -6.41500M -3.30400M -3.84200M -7.94400M
Minority interest - - - - -
Net income -9.48300M -6.30400M -3.22400M -3.68400M -7.69200M
Selling general administrative 8.29M 4.32M 1.70M 1.81M 5.56M
Selling and marketing expenses 4.56M 3.68M 2.88M 3.14M 3.15M
Gross profit 7.17M 5.00M 3.68M 3.60M 5.27M
Reconciled depreciation 0.67M 0.57M 0.64M 0.77M 0.59M
Ebit -9.23800M -6.38100M -3.56800M -4.12700M -8.03300M
Ebitda -8.45700M -5.78700M -2.63400M -3.03000M -7.35500M
Depreciation and amortization 0.78M 0.59M 0.93M 1.10M 0.68M
Non operating income net other - - - - -
Operating income -9.23800M -6.38100M -3.56800M -4.12700M -8.03300M
Other operating expenses 21.00M 14.81M 10.18M 10.56M 16.16M
Interest expense 0.20M 0.06M 0.03M 0.04M 0.00100M
Tax provision 0.04M -0.11100M -0.08000M -0.15800M -0.25200M
Interest income 0.11M 0.03M 0.29M 0.06M 0.07M
Net interest income -0.08400M -0.03400M 0.26M 0.29M 0.09M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.04M -0.11100M -0.08000M -0.15800M -0.25200M
Total revenue 11.77M 8.43M 6.61M 6.44M 8.13M
Total operating expenses 16.41M 11.38M 7.25M 7.73M 13.30M
Cost of revenue 4.60M 3.43M 2.93M 2.83M 2.86M
Total other income expense net -0.20900M -0.03400M 0.26M 0.28M 0.09M
Discontinued operations - - - - -
Net income from continuing ops -9.48300M -6.30400M -3.22400M -3.68400M -7.69200M
Net income applicable to common shares - -6.30400M -3.22400M -3.68400M -7.69200M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 13.82M 18.21M 13.89M 11.82M 13.55M
Intangible assets - 0.00200M 0.00500M 0.03M 0.07M
Earning assets - - - - -
Other current assets - 3.59M 3.03M 3.75M 3.76M
Total liab 4.13M 3.85M 3.33M 1.87M 2.40M
Total stockholder equity 9.69M 14.36M 10.56M 9.95M 11.14M
Deferred long term liab - - - - -
Other current liab - 1.48M 0.81M 0.00100M -0.85500M
Common stock 4.35M 4.33M 3.60M 3.03M 2.59M
Capital stock 4.35M 4.33M 3.60M 3.03M 2.59M
Retained earnings -98.37700M -90.02400M -84.29200M -81.66400M -78.29800M
Other liab - - - - -
Good will 1.62M 1.62M 1.62M 1.62M 1.62M
Other assets - 0.14M 0.30M 0.15M 0.14M
Cash 5.66M 1.00M 0.98M 0.46M 2.46M
Cash and equivalents - - - - -
Total current liabilities 3.73M 3.15M 2.55M 1.76M 2.40M
Current deferred revenue - - - 0.58M -
Net debt -4.75700M 0.14M 0.23M 0.00300M -2.45900M
Short term debt 0.49M 0.44M 0.43M 0.35M 1.82M
Short long term debt 0.06M 0.04M 0.03M - -
Short long term debt total 0.90M 1.14M 1.21M 0.46M -
Other stockholder equity 103.72M 100.06M 91.25M 88.59M 88.55M
Property plant equipment - 1.56M 1.22M 0.89M 0.70M
Total current assets 10.83M 14.89M 10.74M 9.13M 11.02M
Long term investments - - - - -
Net tangible assets - 12.74M 8.94M 8.30M 9.45M
Short term investments - 8.16M 3.17M 1.96M 1.82M
Net receivables 1.37M 2.98M 3.03M 3.75M 3.76M
Long term debt 0.21M 0.22M 0.19M - -
Inventory 3.37M 2.14M 3.57M 2.96M 2.98M
Accounts payable 3.23M 2.71M 2.12M 0.83M 1.43M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -2.36300M -1.68800M
Additional paid in capital - - - - -
Common stock total equity - - 3.60M 3.03M 2.59M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.06M 0.14M 0.22M 0.06M 0.06M
Deferred long term asset charges - - - - -
Non current assets total 3.00M 3.32M 3.14M 2.69M 2.53M
Capital lease obligations 0.63M 0.88M 0.98M 0.46M 0.00000M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 8.01M -5.35200M -1.35200M -0.08100M 0.89M
Change to liabilities - 0.41M 0.71M -0.94100M -0.47500M
Total cashflows from investing activities - -5.35200M -1.19700M -0.13700M 0.88M
Net borrowings - -0.42900M -0.21500M -0.42000M -0.00700M
Total cash from financing activities -0.60100M 8.62M 4.23M 2.54M 6.68M
Change to operating activities - - - - -
Net income -9.48300M -6.30400M -3.22400M -3.68400M -7.69200M
Change in cash 4.65M 0.02M 0.53M -2.00200M 1.28M
Begin period cash flow 1.00M 0.98M 0.46M 2.46M 1.18M
End period cash flow 5.66M 1.00M 0.98M 0.46M 2.46M
Total cash from operating activities -2.71400M -3.21500M -2.49200M -4.40700M -6.27200M
Issuance of capital stock 0.03M 9.06M 4.45M 2.96M 6.69M
Depreciation 0.67M 0.57M 0.64M 0.77M 0.59M
Other cashflows from investing activities - 0.00200M 0.16M 0.06M 0.09M
Dividends paid - - - - -
Change to inventory -1.22700M 1.35M -0.60700M 0.01M -1.43900M
Change to account receivables - -0.49900M 0.60M 0.15M 0.96M
Sale purchase of stock - - 4.45M 2.96M 6.69M
Other cashflows from financing activities -0.62700M -0.43800M -0.21900M -0.42300M -0.00800M
Change to netincome - 1.27M -0.60900M -0.72600M 1.78M
Capital expenditures 0.13M 0.38M 0.01M 0.13M 0.12M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.83M 1.26M 0.70M -0.77100M -0.95300M
Stock based compensation 1.13M 0.57M 0.60M 0.32M 0.80M
Other non cash items 4.14M 0.03M -0.26400M -0.28500M 0.99M
Free cash flow -2.84700M -3.59700M -2.50700M -4.53900M -6.38700M

Peer Comparison

Sector: Basic Materials Industry: Agricultural Inputs

Company Change (GBP) Price (GBP) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PHC
Plant Health Care
- -% - - 21.46 1.06 1.33 0.65 -1.5855
WYN
Wynnstay Group Plc
2.00 0.66% 307.00 5.78 11.09 0.11 0.63 0.13 4.08
EDEN
Eden Research plc
-0.075 1.90% 3.88 - - 17.28 6.73 17.17 -4.9542
EML
Emmerson PLC
0.01 2.24% 0.64 - - - 0.63 -2.5513
KRPZ
Kropz Plc
-1.287 99.00% 0.01 - - 0.99 0.38 4.57 1.03

Reports Covered

Stock Research & News

Profile

Plant Health Care plc, together with its subsidiaries, provides agricultural biological products and technology solutions in the Americas, Mexico, and internationally. It offers products to enhance the yield and quality of crops, such as corn, soybeans, sugar cane, citrus, and rice, as well as fruits and vegetables. The company provides Harpin aß, a recombinant protein, which acts as a biostimulant to enhance the yield and quality of crops; and Saori, a vaccine for plants that promotes healthy growth of soybeans and helps them fight disease. It also distributes third-party biological products. The company was founded in 1995 and is headquartered in Holly Springs, North Carolina.

Plant Health Care

242 South Main Street, Holly Springs, NC, United States, 27540

Key Executives

Name Title Year Born
Mr. Jeffrey Hovey CPA CFO & Exec. Director 1969
Mr. Jeffrey Tweedy CEO, COO & Exec. Director 1968
Ms. Maria Lopez Technical Director & Regulatory Affairs of EMEAA NA
Dr. Zhongmin Wei Chief Science Officer 1957
Mr. Mark Turner Director of Technology Licensing NA
Ms. Meagan Osborn Head of Supply Chain NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions